[Custom Buffer Implementation Case Study] Biopharmaceuticals and Vaccine Handling Industry
We would like to introduce a case of contract manufacturing your original composition buffer! We also provide support for long-term stability testing.
We would like to introduce a case study of the implementation of "Custom Buffer" in the industry engaged in biopharmaceuticals, vaccines, and gene therapy. The customer faced challenges such as "having no space to prepare new preparation tanks" and "not having a manufacturing contractor due to the short time from composition confirmation to manufacturing." After the implementation, we were able to provide sterile products within three months of the customer's request and deliver products according to the customer's timing of use. [Case Overview (Partial)] ■Challenges - No space to prepare new preparation tanks - No manufacturing contractor due to the short time from composition confirmation to manufacturing - Desire to reduce the time for buffer preparation - Need for flexible response due to fluctuating usage quantities depending on the development items - No storage space, so we want the necessary quantities delivered at the desired timing *For more details, please refer to the related links or feel free to contact us.
Inquire About This Product
basic information
【Other Case Summary】 ■Solutions and Offerings - Provided sterile products within three months of the customer's request - Established a stable supply system in collaboration with a single-use bag manufacturer - Delivered products in accordance with the customer's usage timing - Supported long-term stability testing *For more details, please refer to the related links or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
【Usage】 ■ Buffer for purification *For more details, please refer to the related links or feel free to contact us.
catalog（2）
Download All Catalogs
Company information
In June 2018, we established Ajinomoto Koji Bio Co., Inc. as a joint venture between Ajinomoto Co., Inc. and Koji Bio Co., Inc. We combined Ajinomoto Co., Inc.'s high-quality amino acids as the foundation for culture media raw materials and their formulation development technology with Koji Bio Co., Inc.'s advanced liquid culture media production technology to launch a contract manufacturing company for clinical culture media necessary for regenerative medicine. Currently, we are engaged in contract manufacturing of liquid media and buffers for customers in cell therapy and biopharmaceuticals, enhancing our significance in the industry.